Advanced Development of an Ebola Vaccine
$8,069,468N01FY2014AINIH
Janessen Vaccines And Prevention, Bv, Leiden
Investigators
Abstract
This contract supports advanced development of an Ebola vaccine; support may be provided through early clinical development.
View original record on NIH RePORTER →